Alterity Therapeutics (ATHE) Current Assets (2017 - 2018)
Alterity Therapeutics (ATHE) has 2 years of Current Assets data on record, last reported at $14.1 million in Q2 2018.
- For Q2 2018, Current Assets fell 25.55% year-over-year to $14.1 million; the TTM value through Jun 2018 reached $14.1 million, down 25.55%, while the annual FY2018 figure was $14.1 million, 25.83% down from the prior year.
- Current Assets reached $14.1 million in Q2 2018 per ATHE's latest filing, down from $19.0 million in the prior quarter.
- Across five years, Current Assets topped out at $19.0 million in Q2 2017 and bottomed at $14.1 million in Q2 2018.